Enrique Carrazana
2014
In 2014, Enrique Carrazana earned a total compensation of $1.7M as Chief Medical Officer at Acorda Therapeutics, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $231,351 |
|---|---|
| Option Awards | $719,763 |
| Salary | $434,000 |
| Stock Awards | $259,908 |
| Other | $18,677 |
| Total | $1,663,699 |
Carrazana received $719.8K in option awards, accounting for 43% of the total pay in 2014.
Carrazana also received $231.4K in non-equity incentive plan, $434K in salary, $259.9K in stock awards and $18.7K in other compensation.
Rankings
In 2014, Enrique Carrazana's compensation ranked 5,321st out of 13,032 executives tracked by ExecPay. In other words, Carrazana earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,321 out of 13,032 | 59th |
Division Manufacturing | 1,902 out of 4,966 | 62nd |
Major group Chemicals And Allied Products | 639 out of 1,686 | 62nd |
Industry group Drugs | 490 out of 1,365 | 64th |
Industry Biological Products, Except Diagnostic Substances | 86 out of 236 | 64th |
Source: SEC filing on April 29, 2016.
Carrazana's colleagues
We found six more compensation records of executives who worked with Enrique Carrazana at Acorda Therapeutics in 2014.
2014
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2014
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2014
Jane Wasman
Acorda Therapeutics
General Counsel
2014
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2014
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
2014
Michael Rogers
Acorda Therapeutics